Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges

Abstract Background The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and international immobility. Vaccination represents the only mechanism to defeat this virus. Several intramuscular vaccines...

Полное описание

Библиографические подробности

Главные авторы:	Sanchita Kar, Popy Devnath, Talha B. Emran, Trina E. Tallei, Saikat Mitra, Kuldeep Dhama
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wiley 2022-04-01
Серии:	Immunity, Inflammation and Disease
Предметы:	COVID‐19 intranasal vaccines mass vaccination mucosal vaccines oral vaccines SARS‐CoV‐2
Online-ссылка:	https://doi.org/10.1002/iid3.604
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!